2.80
2.80 (0%)
As of Feb 14, 2025
Mustang Bio, Inc. [MBIO]
Source:
Company Overview
Mustang Bio, Inc is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs into potential cures for difficult-to-treat cancers and autoimmune diseases.
| Country | United States |
| Headquarters | worcester, massachusetts |
| Phone Number | (781) 652-4500 |
| Industry | manufacturing |
| CEO | Manuel Litchman |
| Website | www.mustangbio.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-16.2 |
| Net Income | $-15.8 |
| Net Cash | $-0.1 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -116.5% |
| Profit as % of Stockholder Equity | 406.7% |
Management Effectiveness
| Return on Equity | 406.7% |
| Return on Assets | -169.2% |
| Turnover Ratio | |
| EBITA | $-16.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $9.3 |
| Total Liabilities | $13.2 |
| Operating Cash Flow | $-11.4 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $11.3 |
